Detection of low levels of SARS-CoV-2 RNA from nasopharyngeal swabs using three commercial molecular assays

In response to the COVID-19 pandemic, commercial molecular assays for SARS-CoV-2 testing have been rapidly developed and broadly deployed in laboratories worldwide. Although these assays have been reported to correlate well, we sought to compare the Xpert® Xpress SARS-CoV-2 to the cobas® SARS-CoV-2...

Descripción completa

Detalles Bibliográficos
Autores principales: Lowe, Christopher F., Matic, Nancy, Ritchie, Gordon, Lawson, Tanya, Stefanovic, Aleksandra, Champagne, Sylvie, Leung, Victor, Romney, Marc G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7187880/
https://www.ncbi.nlm.nih.gov/pubmed/32380382
http://dx.doi.org/10.1016/j.jcv.2020.104387

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7187880/
https://www.ncbi.nlm.nih.gov/pubmed/32380382
http://dx.doi.org/10.1016/j.jcv.2020.104387

Ejemplares similares